Abstract: The present invention relates to a pharmaceutical composition for preventing or treating attention deficit/hyperactivity disorder (ADHD), including SNAP5114 as an active ingredient. A Git1 gene-deficient hetero (+/?) mouse, confirmed to have increased amount of GABA in the brain striatum that controls hyperactivity, can be used as an animal model of ADHD, and by confirming that hyperactivity is ameliorated by administering SNAP5114 to the Git1 gene-deficient hetero (+/?) mouse, SNAP5114 is provided as a therapeutic agent for ADHD.

Abstract: The present inventive concept relates to a chemically modified anion exchange membrane and a method of preparing the same and, more particularly, an anion exchange membrane in which sulfonic acid groups in a perfluorinated sulfonic acid electrolyte membrane are substituted with anion conductive groups such as an ammonium group, a phosphonium group, an imidazolium group, a pyridinium group and a sulfonium group, and a method of preparing an anion exchange membrane by chemically modifying sulfonic acid groups in a perfluorinated sulfonic acid electrolyte membrane.

Abstract: The present invention relates to a method for recovering an ionomer or catalyst from a used or defective membrane electrode assembly or ion exchange membrane, the method comprising the steps of: subjecting the membrane electrode assembly or ion exchange membrane to supercritical dispersion in a mixed solvent of alcohol and water to extract the ionomer, filtering and separating the extracted ionomer dispersion liquid; and filtering and separating the catalyst from the remaining components after the separation of the ionomer dispersion liquid.

Abstract: The present invention relates to a method for manufacturing a membrane-electrode assembly and a membrane-electrode assembly manufactured thereby, and more specifically, to a method for manufacturing a membrane-electrode assembly by using a nano-dispersed ionomer binder under supercritical conditions in a mixed solvent comprising alcohol and water, and a membrane-electrode assembly manufactured thereby and a fuel cell or water electrolysis device comprising same.

Abstract: A method of evaluating quality of graphene using a confocal laser scanning microscope, the method comprising steps of: irradiating with laser light a graphene layer formed on a catalyst layer; detecting a signal of light reflected from the graphene layer; forming a planar image of the graphene layer using the detected optical signal; and analyzing a contrast between graphene and the catalyst layer in the planar image, wherein the graphene layer is continuously formed on the catalyst layer by a roll-to-roll process.

Abstract: The present invention relates to: a method for preparing a nanocomposite of an ionomer and a metal oxide acting as a radical scavenger; and a fuel cell comprising a nanocomposite prepared thereby and, more specifically, to: a method for preparing a highly-dispersible radical scavenger metal oxide-ionomer nanocomposite which can be redispersed to the size of nanoparticles in an aqueous alcohol solution or an ionomer solution; and a membrane electrode assembly and fuel cell comprising a nanocomposite prepared thereby.

Abstract: The present invention relates to a composition for the differentiation of dental pulp stem cells into odontoblasts and an IgG or IgM type monoclonal antibody that specifically binds to the surface of odontoblasts differentiated from the stem cells. According to the present invention, BMP2 and BMP4 are optimally combined to significantly increase the differentiation efficiency of dental pulp stem cells into odontoblasts, to induce the mineralization of the matrix, and to improve the differentiation ability of odontoblasts into dentin. Further, the IgG or IgM monoclonal antibody that specifically binds to the surface of odontoblasts of the present invention is used to effectively isolate and purify odontoblasts, which can be useful for tissue regeneration and differentiation.

Abstract: The polymer electrolyte membrane includes: a first ion conductive polymer layer; and a second ion conductive polymer layer disposed on at least one surface of the first ion conductive polymer layer, wherein the first ion conductive polymer layer comprises a first ion conductive polymer comprising a sulfonic acid group, wherein the second ion conductive polymer layer comprises a second ion conductive polymer comprising a carboxylic acid group, and wherein a thickness of the second ion conductive polymer layer is in a range of 1% to 80% of a thickness of the polymer electrolyte membrane. Further, disclosed are the method for preparing the same, the membrane-electrode assembly including the same, and the fuel cell including the same.

Abstract: A display device including: a display panel; a cover plate disposed on the display panel; and an adhesive layer disposed between the display panel and the cover plate, wherein the adhesive layer includes a main adhesive layer and a thin film layer, the thin film layer includes a first thin film layer and a second thin film layer disposed on the first thin film layer, the first thin film layer contains a siloxane functional group and the second thin film layer contains fluorine, and the second thin film layer is disposed between the first thin film layer and the cover plate.

Abstract: The present invention relates to a separator for a lithium secondary battery, a method for manufacturing the separator, and a lithium secondary battery including the separator. The separator includes a porous substrate and a heat resistance porous layer positioned on at least one surface of the porous substrate, wherein the heat resistance porous layer includes a sulfonic acid group-containing polysulfone.

Abstract: Disclosed are: an ionomer nanoparticle dispersion solution formed by dispersing a perfluorinated ionomer having an ion conductive functional group in a solvent mixture including water and an alcohol, and carrying out a reaction under a supercritical condition; and a preparation method thereof. The ionomer nanoparticle dispersion solution has a high azeotropic mixture content in a continuous phase, which is a liquid phase, so as to readily remove a solvent therefrom, and thus a product using the ionomer nanoparticle dispersion solution can be readily fabricated and preparation costs can be reduced. In addition, uniformity of the product is improved because a perfluorinated ionomer having various ion conductive functional groups and various salts thereof is nano-dispersed, in a narrow molecular weight distribution, in the ionomer nanoparticle dispersion solution.

Abstract: The present disclosure provides an apparatus generating spinal cord contusive model of animals, including an external fixation member fixed outside a body of an experiment animal, an impactor configured to impart a spinal cord of the experiment animal, and an impactor guide member fixed to the external fixation member to guide a fall of the impactor, wherein the impactor is provided with an acceleration sensor.

Abstract: The present invention relates to: a porous polymer material having a porous structure over the entire polymer and having a dense porous structure in which pores are connected to each other therein. The porous polymer material is harmless to the human body as it does not use toxic organic solvents. In addition, a porous polymer material can be prepared without using any additives for forming pores and the particle size can be easily controlled, and thus a polymer material suitable for various uses can be prepared. Furthermore, the extended release of a loaded bioactive material is possible only by the dense porous structure of a polymer itself without using an additive and a surface modification method in the porous polymer material of the present invention. Therefore, the porous polymer material can be applied to a biodegradable material in various bio-fields requiring the extended release of a bioactive material.

Abstract: The present disclosure relates to a use of a phloroglucinol-based compound and its salt for preventing and treating Alzheimer's disease. The pharmaceutical composition for preventing or treating Alzheimer's disease of the present disclosure fundamentally suppresses the cause of ?-amyloid formation, thereby exerting a remarkable effect of allowing ultimate treatment of Alzheimer's disease. The present disclosure provides the use of the single substance, which has been isolated from Dryopteris crassirhizoma and identified, for preventing or treating Alzheimer's disease for the first time.

Abstract: The present invention relates to: a porous polymer material having a porous structure over the entire polymer and having a dense porous structure in which pores are connected to each other therein. The porous polymer material is harmless to the human body as it does not use toxic organic solvents. In addition, a porous polymer material can be prepared without using any additives for forming pores and the particle size can be easily controlled, and thus a polymer material suitable for various uses can be prepared. Furthermore, the extended release of a loaded bioactive material is possible only by the dense porous structure of a polymer itself without using an additive and a surface modification method in the porous polymer material of the present invention. Therefore, the porous polymer material can be applied to a biodegradable material in various bio-fields requiring the extended release of a bioactive material.